Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 9

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Myelodysplastic neoplasms evolving from inherited bone marrow failure syndromes / germline predisposition syndromes: Back under the microscope

Elghetany, M. Tarek, Patnaik, Mrinal M., Khoury, Joseph D.·2024·Leukemia Research
DOI 10.1016/j.leukres.2024.107441
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.leukres.2024.107441

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 59

  1. Choijilsuren, 2021, Mechanisms of somatic transformation in inherited bone marrow failure syndromes, Am. Soc. Hematol. Educ. Program Hematol., 390, 10.1182/hematology.2021000271 · DOI
  2. Cada, 2015, The impact of category, cytopathology and cytogenetics on development and progression of clonal and malignant myeloid transformation in inherited bone marrow failure syndromes, Haematologica, 100, 633, 10.3324/haematol.2014.117457 · DOI
  3. Alter, 2018, Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up, Haematologica, 103, 30, 10.3324/haematol.2017.178111 · DOI · Paper page
  4. Schratz, 2020, Cancer spectrum and outcomes in the Mendelian short telomere syndromes, Blood, 135, 1946, 10.1182/blood.2019003264 · DOI
  5. Kennedy, 2019, Genetic predisposition to MDS: clinical features and clonal evolution, Blood, 133, 1071, 10.1182/blood-2018-10-844662 · DOI · Paper page
  6. Gener-Ricos, 2023, Germline predisposition to myelodysplastic syndromes, Cancer J., 29, 143, 10.1097/PPO.0000000000000660 · DOI
  7. Myers, 2020, Myelodysplastic syndrome and acute myeloid leukemia in patients with Shwachman Diamond syndrome: a multicentre, retrospective, cohort study, Lancet Hematol., 7, e238, 10.1016/S2352-3026(19)30206-6 · DOI
  8. Merfort, 2022, Cytogenetics in Fanconi anemia: the importance of follow-up and the search for new biomarkers of genomic instability, Int J. Mol. Sci., 23, 14119, 10.3390/ijms232214119 · DOI
  9. Khoury, 2022, The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms, Leukemia, 36, 1703, 10.1038/s41375-022-01613-1 · DOI · Paper page
  10. Bennett, 1982, Proposals for the classification of the myelodysplastic syndrome, Br. J. Haematol., 51, 189, 10.1111/j.1365-2141.1982.tb08475.x · DOI · Paper page
  11. Greenberg, 2012, Revised international prognostic scoring system for myelodysplastic syndromes, Blood, 120, 2454, 10.1182/blood-2012-03-420489 · DOI · Paper page
  12. Garcia-Manero, 2020, Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management, Am. J. Hematol., 95, 1399, 10.1002/ajh.25950 · DOI · Paper page
  13. Cazzola, 2020, Myelodysplastic syndromes, N. Eng. J. Med, 383, 1358, 10.1056/NEJMra1904794 · DOI · Paper page
  14. Brett, 2023, The presence of chromosomal abnormality in cytopenia without dysplasia identifies a category of high-risk clonal cytopenia of unknown significance, Genes Chromosomes Cancer, 62, 139, 10.1002/gcc.23107 · DOI
  15. Capuozzo, 2022, p53: from fundamental biology to clinical applications in cancer, Biology, 11, 1325, 10.3390/biology11091325 · DOI · Paper page
  16. Ferrer A., Lasho T., Fernandez J.A., Steinauer N.P., Simon R.A., Finke C.M., et al. Patients with telomere biology disorders show context somatic mosaic states with high frequency of U2AF1 variants. Am J Hematol. https://doi.org/10.1002/ajh.27086. · DOI
  17. Tsai, 2020, Clonal hematopoiesis in inherited bone marrow failure syndromes, Blood, 136, 1615
  18. Kennedy, 2021, Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome, Nat. Commun., 12, 10.1038/s41467-021-21588-4 · DOI · Paper page
  19. Maryoung, 2017, Somatic mutations in telomere promoter counterbalance germline loss-of-function mutations, J. Clin. Invest, 127, 982, 10.1172/JCI91161 · DOI
  20. Schratz, 2021, Somatic reversion impacts myelodysplastic syndromes and acute leukemia evolution in the short telomere disorders, J. Clin. Invest, 131, 10.1172/JCI147598 · DOI
  21. Revy, 2023, Genetics of human telomere biology disorders, Nat. Rev. Gen., 24, 86, 10.1038/s41576-022-00527-z · DOI · Paper page
  22. Sebert, 2023, Clonal hematopoiesis driven by chromosome1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia, Cell Stem Cell, 30, 153, 10.1016/j.stem.2023.01.006 · DOI
  23. Sahoo, 2021, Clinical evolution, genetic landscape, and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes, Nat. Med, 27, 1806, 10.1038/s41591-021-01511-6 · DOI · Paper page
  24. Shimamura, 2010, Pathophysiology and management of inherited bone marrow failure syndromes, Blood Rev., 24, 101, 10.1016/j.blre.2010.03.002 · DOI · Paper page
  25. Donadieu, 2012, Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-diamond syndrome, Haematologica, 97, 1312, 10.3324/haematol.2011.057489 · DOI · Paper page
  26. Dufour, 2017, How I manage patients with Fanconi anaemia, Br. J. Haematol., 178, 32, 10.1111/bjh.14615 · doi:10.1111/bjh.14615
  27. Alter, 2000, Fanconi anemia: myelodysplasia as a predictor of outcome, Cancer Genet Cytogenet, 117, 125, 10.1016/S0165-4608(99)00159-4 · DOI
  28. Furutani, 2022, Hematologic complications with age in Shwachman-Diamond syndrome, Blood Adv., 6, 297, 10.1182/bloodadvances.2021005539 · doi:10.1182/bloodadvances.2021005539
  29. Kanagal-Shamanna, 2017, Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation, Haematologica, 102, 1661, 10.3324/haematol.2017.167726 · DOI
  30. Cunningham, 2023, Natural study of patients with familial platelet disorder with associated myeloid malignancy, Blood, 142, 2146, 10.1182/blood.2023019746 · DOI
  31. McReynolds, 2018, Germline GATA2 mutation and bone marrow failure, Hematol. Oncol. Clin. North Am., 32, 713, 10.1016/j.hoc.2018.04.004 · DOI
  32. Bluteau, 2018, A landscape of germline mutations in a cohort of inherited bone marrow failure patients, Blood, 131, 717, 10.1182/blood-2017-09-806489 · DOI · Paper page
  33. Cioc, 2010, Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with Fanconi anemia, Am. J. Clin. Pathol., 133, 92, 10.1309/AJCP7W9VMJENZOVG · DOI
  34. Dror, 2011, Draft consensus guidelines for diagnosis and treatment of Shwachman-diamond syndrome, Ann. NY Acad. Sci., 1242, 40, 10.1111/j.1749-6632.2011.06349.x · DOI · Paper page
  35. Chisholm, 2019, Bone marrow morphology associated with germline RUNX1 mutations in patients with familial platelet disorder with associated myeloid malignancy, Pedia Dev. Pathol., 22, 315, 10.1177/1093526618822108 · DOI
  36. Rudelius, 2023, The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia, Virchows Arch., 482, 113, 10.1007/s00428-022-03447-9 · DOI
  37. Hastle, 2003, A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases, Leukemia, 17, 277, 10.1038/sj.leu.2402765 · DOI · Paper page
  38. Behrens, 2021, A novel classification of hematologic conditions in patients with Fanconi anemia, Haematologica, 106, 3000, 10.3324/haematol.2021.279332 · DOI
  39. Peffault de Latour, 2013, Allogeneic stem cell transplantation in Fanconi anemia: the European Group for, Blood Marrow Transplant. Blood, 122, 4279
  40. Wlodarski, 2016, Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents, Blood, 127, 1387, 10.1182/blood-2015-09-669937 · DOI · Paper page
  41. Nakano, 2020, Diagnosis and treatment of pediatric myelodysplastic syndromes: a survey of the North American Pediatric Aplastic Anemia Consortium, Pedia Blood Cancer, 67, 10.1002/pbc.28652 · DOI
  42. Peffault de Latour, 2016, How I treat MDS and AML in Fanconi anemia, Blood, 127, 2971, 10.1182/blood-2016-01-583625 · DOI
  43. Pezeshki, 2017, Mosomy 7/de (7q) in inherited bone marrow failure syndromes: a systematic review, Pedia Blood Cancer, 64, 10.1002/pbc.26714 · doi:10.1002/pbc.26714
  44. Mehta, 2010, Numerical chromosomal changes and risk of development of myelodysplastic syndrome-acute myeloid leukemia in patients with Fanconi anemia, Cancer Genet Cytogenet, 203, 180, 10.1016/j.cancergencyto.2010.07.127 · DOI
  45. Sande C.M., Chen S., Mitchell D.V., Lin P., Deolikar R.J., Freeman C., et al. DNA damage response constrains cell growth and drives clonal hematopoiesis in telomere biology disorders. Annual Meeting of the American Society of Hematology, San Diego, December 2023, Abstract 1356. · doi:10.1182/blood-2023-173666
  46. Homan, 2023, Somatic mutational landscape of hereditary hematopoietic malignancies caused by germ line RUNX1, GATA2, and DDX41 variants, Blood Adv., 7, 6092, 10.1182/bloodadvances.2023010045 · DOI
  47. Badar T., Lasho T.L., Kusne Y., Marando L., Mangaonkar A.A., Finke C.M., et al. Clinical and molecular spectrum of somatic mosaic states in DDX41 mutant germline predisposition syndromes. Annual Meeting of the American Society of Hematology, San Diego, December 2023, Abstract 4618. · doi:10.1182/blood-2023-187310
  48. Savage, 2018, Myelodysplastic syndrome, acute myeloid leukemia, and cancer surveillance in Fanconi anemia, Hematol. Oncol. Clin. North Am., 32, 657, 10.1016/j.hoc.2018.04.002 · DOI
  49. Badar, 2022, Germline and somatic defects in DDX41 and its impact on myeloid neoplasms, Curr. Hematol. Malig. Rep., 17, 113, 10.1007/s11899-022-00667-3 · DOI
  50. Largeaud, 2023, Somatic genetic alterations predict hematological progression in GATA2 deficiency, Haematologica, 108, 1515, 10.3324/haematol.2022.282250 · DOI
  51. Elghetany, 1998, Significance of p53 overexpression in bone marrow biopsies from patients with bone marrow failure: aplastic anemia, hypocellular refractory anemia, and hypercellular refractory anemia, Ann. Hematol., 77, 261, 10.1007/s002770050455 · doi:10.1007/s002770050455
  52. Elghetany, 2002, P53 protein overexpression in bone marrows of patients with Shwachman-Diamond syndrome has a prevalence similar to patients with refractory anemia, Arch. Pathol. Lab Med., 126, 452, 10.5858/2002-126-0452-PPOIBM · DOI
  53. Della Porta, 2015, Minimal morphologic criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes., Leukemia, 29, 66, 10.1038/leu.2014.161 · DOI
  54. Aqil, 2016, Are micromegakaryocytes specific for refractory cytopenia of childhood (RCC)? A study of 38 patients with thrombocytopenia unrelated to RCC, Leuk. Res, 47, 84, 10.1016/j.leukres.2016.05.015 · doi:10.1016/j.leukres.2016.05.015
  55. Bennett, 2009, Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach, Haematologica, 94, 264, 10.3324/haematol.13755 · DOI · Paper page
  56. Alter, 2003, The CCC System: is it really the answer to pediatric MDS?, J. Pedia Hematol. Oncol., 25, 426, 10.1097/00043426-200305000-00016 · DOI
  57. Parmentier, 2012, Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors, Haematologica, 97, 723, 10.3324/haematol.2011.056879 · DOI
  58. Elghetany, 1997, Peripheral blood picture in primary hypocellular refractory anemia and idiopathic acquired aplastic anemia: an additional tool for differential diagnosis, Haematologica, 82, 21
  59. Germing, 2012, Evaluation of dysplasia through detailed cytopmorphology in 3156 patients from the Düsseldorf Registry on myelodysplastic syndromes, Leuk. Res, 36, 727, 10.1016/j.leukres.2012.02.014 · DOI

Cited by

See all 9

Metadata

Authors
Elghetany, M. T., Patnaik, M. M., & Khoury, J. D.
Venue
Leukemia Research
Publisher
Elsevier BV
Published
2024-02
Volume
137
Pages
107441
ISSN
0145-2126
DOI
10.1016/j.leukres.2024.107441
Cited by
9
References
2
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Myelodysplastic neoplasms evolving from inherited bone marrow failure syndromes / germline predisposition syndromes: Back under the microscope. https://app.cochat.ai/papers/10.1016/j.leukres.2024.107441
The paper
Elghetany, M. T., Patnaik, M. M., & Khoury, J. D. (2024). Myelodysplastic neoplasms evolving from inherited bone marrow failure syndromes / germline predisposition syndromes: Back under the microscope. Leukemia Research. https://doi.org/10.1016/j.leukres.2024.107441

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.